Boyle G - Search Results

1

Cryptic Epoxytiglianes from the Kernels of the Blushwood Tree (Fontainea picrosperma).

Chianese G, Amin HIM, Maioli C, Reddell P, Parsons P, Cullen J, Johns J, Handoko H, Boyle G, Appendino G, Taglialatela-Scafati O, Gaeta S. Chianese G, et al. Among authors: boyle g. J Nat Prod. 2022 Aug 26;85(8):1959-1966. doi: 10.1021/acs.jnatprod.2c00226. Epub 2022 Aug 16. J Nat Prod. 2022. PMID: 35973043 Free PMC article. Review.

2

Screening of human primary melanocytes of defined melanocortin-1 receptor genotype: pigmentation marker, ultrastructural and UV-survival studies.

Leonard JH, Marks LH, Chen W, Cook AL, Boyle GM, Smit DJ, Brown DL, Stow JL, Parsons PG, Sturm RA. Leonard JH, et al. Among authors: boyle gm. Pigment Cell Res. 2003 Jun;16(3):198-207. doi: 10.1034/j.1600-0749.2003.00033.x. Pigment Cell Res. 2003. PMID: 12753386

3

What is transforming growth factor-beta (TGF-beta)?

Chin D, Boyle GM, Parsons PG, Coman WB. Chin D, et al. Among authors: boyle gm. Br J Plast Surg. 2004 Apr;57(3):215-21. doi: 10.1016/j.bjps.2003.12.012. Br J Plast Surg. 2004. PMID: 15006522 Review.

4

Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death.

Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, McAlpine D, Johns J, Scott TM, Sutherland KP, Gardner JM, Le TT, Lenarczyk A, Aylward JH, Parsons PG. Ogbourne SM, et al. Among authors: boyle gm. Cancer Res. 2004 Apr 15;64(8):2833-9. doi: 10.1158/0008-5472.can-03-2837. Cancer Res. 2004. PMID: 15087400

5

Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.

Glenn MP, Kahnberg P, Boyle GM, Hansford KA, Hans D, Martyn AC, Parsons PG, Fairlie DP. Glenn MP, et al. Among authors: boyle gm. J Med Chem. 2004 Jun 3;47(12):2984-94. doi: 10.1021/jm030222i. J Med Chem. 2004. PMID: 15163181

6

Molecular introduction to head and neck cancer (HNSCC) carcinogenesis.

Chin D, Boyle GM, Theile DR, Parsons PG, Coman WB. Chin D, et al. Among authors: boyle gm. Br J Plast Surg. 2004 Oct;57(7):595-602. doi: 10.1016/j.bjps.2004.06.010. Br J Plast Surg. 2004. PMID: 15380692 Review.

7

Novel markers for poor prognosis in head and neck cancer.

Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG, Coman WB. Chin D, et al. Among authors: boyle gm. Int J Cancer. 2005 Feb 20;113(5):789-97. doi: 10.1002/ijc.20608. Int J Cancer. 2005. PMID: 15499618 Free article.

8

Histone deacetylase inhibitors and malignant melanoma.

Boyle GM, Martyn AC, Parsons PG. Boyle GM, et al. Pigment Cell Res. 2005 Jun;18(3):160-6. doi: 10.1111/j.1600-0749.2005.00228.x. Pigment Cell Res. 2005. PMID: 15892712 Review.

9

Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer.

Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG, Coman WB. Chin D, et al. Among authors: boyle gm. Laryngoscope. 2005 Jul;115(7):1239-42. doi: 10.1097/01.MLG.0000164715.86240.55. Laryngoscope. 2005. PMID: 15995513

10

Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer.

Newton TR, Parsons PG, Lincoln DJ, Cummings MC, Wyld DK, Webb PM, Green AC, Boyle GM. Newton TR, et al. Among authors: boyle gm. Int J Cancer. 2006 Aug 15;119(4):875-83. doi: 10.1002/ijc.21823. Int J Cancer. 2006. PMID: 16557592 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

379 results

Search Page